Headway Platform
Mental health care platform connecting patients with therapists and psychiatrists
Company profile
Company profile
Headway is a mental health care technology company that builds a national network of therapists and psychiatrists who accept insurance. The platform addresses a critical gap in mental healthcare access by making it easier for patients to find in-network mental health providers and for providers to accept insurance without administrative burden. Headway handles the complex insurance credentialing process, billing, and administrative overhead that typically prevents many mental health professionals from accepting insurance. For patients, the platform offers an easy way to search for and book appointments with licensed therapists and psychiatrists who accept their insurance coverage. The company's mission centers on improving access to affordable mental health care by removing barriers on both the provider and patient sides of the equation. By building technology that streamlines insurance operations and practice management, Headway enables more mental health professionals to grow sustainable practices while accepting insurance, ultimately expanding the network of accessible, affordable mental health services across the United States.
Company description Headway official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Mental health care platform connecting patients with therapists and psychiatrists
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
JMIR mental health · Aug 19, 2026
Personality change after traumatic brain injury: a systematic review and meta-analysis.Journal of neurology · Aug 3, 2026
Chloroethylnitrosourea analogue HJ03 overcomes temozolomide resistance of glioblastoma in mice through induction of ferroptosis and apoptosis.Acta pharmacologica Sinica · Jul 1, 2026
Increased utilization of health care services for non-communicable diseases during the COVID-19 pandemic among refugees in Jordan: a mixed-methods study.Conflict and health · May 14, 2026
Neutron and gamma radiation shielding properties of transparent polymethyl methacrylate copolymers containing gadolinium.Scientific reports · Apr 17, 2026
Disinfection by-products in ballast water treated with oxidants - effects of treatment type, filter pre-treatment, test location, and salinity.Chemosphere · Apr 1, 2026
Clinical validation
NCT07078981 · Mentioned · NOT YET RECRUITING
Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory EvaluationsNCT04856566 · Mentioned · COMPLETED
Neuroscience of Marijuana Impaired DrivingNCT02757313 · Mentioned · COMPLETED
Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory EvaluationsNCT03191084 · Mentioned · COMPLETED
Cannabinol Use in Patients With Insomnia DisorderNCT05344170 · Mentioned · COMPLETED
Neuroscience of Alcohol and Marijuana Impaired DrivingNCT03431987 · Mentioned · UNKNOWN
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Headway's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.